Started: 11/2020

Study Name: A randomized, double-blind, placebo-controlled, multicenter, 16-week trial to evaluate the efficacy and safety of xxx in children, adolescent and adult subjects (ages 2 years and older) with mild to moderate atopic dermatitis

Indication: Atopic Dermatitis

Principal Investigator: Sahra Niazi